Clinical trial
Sentinel Node After Neoadjuvancy In Node-Positive Breast Cancer: SANA Multicentric Study
NCT04865549 is registered in ClinicalTrials.gov with Hospital Clinic of Barcelona as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sentinel Node After Neoadjuvancy In Node-Positive Breast Cancer: SANA Multicentric Study
- Lead sponsor
- Hospital Clinic of Barcelona
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 1, 2016
- Completion date
- January 1, 2021
- Enrollment
- 90 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer